Furthermore, knocking down CTNNA3 in cardiomyocytes resulted in reduced plakophilin 2 expression, mirroring ARVC’s pathological features [96]. This evidence concerns the gene CTNNA3 and arrhythmogenic right ventricular cardiomyopathy.